# Vasopressin in Traumatic Hemorrhagic Shock Study

> **NCT00379522** · PHASE2,PHASE3 · COMPLETED · sponsor: **Volker Wenzel** · enrollment: 64 (actual)

## Conditions studied

- Shock
- Hypovolemia
- Hemorrhagic Shock

## Interventions

- **DRUG:** Vasopressin
- **DRUG:** Saline placebo

## Key facts

- **NCT ID:** NCT00379522
- **Lead sponsor:** Volker Wenzel
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379522, "Vasopressin in Traumatic Hemorrhagic Shock Study". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00379522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*